PPP2R2B and neoplasm: Figure 10a revealed that basal-like subtype had higher tumor mutation burden (TMB), which could initiate tumorigenesis and, conversely, activate CD8 T cells to improve anti-tumor responses [41–43] .In this analysis, TNBC patients were classified into two subgroups based on PPP2R2B median expression.